ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Qian Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4413-9744; OpenAlex author ID A5022946682. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC. Co-author DOI 10.1016/j.ymthe.2025.09.004 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Berina Šabanović · 1 shared paper, 2025 · strength 0.22
- Paper Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemore… DOI 10.1016/j.ymthe.2025.09.004 ↗
Quan Zheng · 1 shared paper, 2025 · strength 0.22
- Paper Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemore… DOI 10.1016/j.ymthe.2025.09.004 ↗
Chenlei Wen · 1 shared paper, 2025 · strength 0.22
- Paper Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemore… DOI 10.1016/j.ymthe.2025.09.004 ↗
Baiyong Shen · 1 shared paper, 2025 · strength 0.22
- Paper Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemore… DOI 10.1016/j.ymthe.2025.09.004 ↗
Christopher Heeschen · 1 shared paper, 2025 · strength 0.22
- Paper Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemore… DOI 10.1016/j.ymthe.2025.09.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.